Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.1900
+0.0050 (2.70%)
Sep 2, 2026, 1:14 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 54.7 million as of September 2, 2026. Its market cap has increased by 1.33% in one year.
Market Cap
54.70M
Enterprise Value
49.59M
Revenue
802.46K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
ChartMarket Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 54.70M, an increase of 556.84%. That is a compound annual growth rate of 6.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 54.70M | 25.14% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 345.23M |
| Vector Science and Therapeutics | 336.18M |
| Cannabix Technologies | 58.35M |
| Perimeter Medical Imaging AI | 43.73M |
| Cheelcare | 28.79M |
| Conavi Medical | 22.77M |
| Ventripoint Diagnostics | 18.15M |
| MedX Health | 16.40M |